Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERCURY II: Rosuvastatin Switching Study
NCT00654407Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2001
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Nov 2001; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00654407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654407.